FH
Fumarate hydratase, mitochondrial
Also known as: FUMH_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07954
- Gene
- FH
- Ensembl
- ENSG00000091483
- Chromosome
- 1
- Canonical length
- 510 aa
- Protein class
- Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is an enzymatic component of the tricarboxylic acid (TCA) cycle, or Krebs cycle, and catalyzes the formation of L-malate from fumarate. It exists in both a cytosolic form and an N-terminal extended form, differing only in the translation start site used. The N-terminal extended form is targeted to the mitochondrion, where the removal of the extension generates the same form as in the cytoplasm. It is similar to some thermostable class II fumarases and functions as a homotetramer. Mutations in this gene can cause fumarase deficiency and lead to progressive encephalopathy. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
510 residues, UniProt reviewed canonical sequence.
>P07954|FH
1 MYRALRLLAR SRPLVRAPAA ALASAPGLGG AAVPSFWPPN AARMASQNSF RIEYDTFGEL
61 KVPNDKYYGA QTVRSTMNFK IGGVTERMPT PVIKAFGILK RAAAEVNQDY GLDPKIANAI
121 MKAADEVAEG KLNDHFPLVV WQTGSGTQTN MNVNEVISNR AIEMLGGELG SKIPVHPNDH
181 VNKSQSSNDT FPTAMHIAAA IEVHEVLLPG LQKLHDALDA KSKEFAQIIK IGRTHTQDAV
241 PLTLGQEFSG YVQQVKYAMT RIKAAMPRIY ELAAGGTAVG TGLNTRIGFA EKVAAKVAAL
301 TGLPFVTAPN KFEALAAHDA LVELSGAMNT TACSLMKIAN DIRFLGSGPR SGLGELILPE
361 NEPGSSIMPG KVNPTQCEAM TMVAAQVMGN HVAVTVGGSN GHFELNVFKP MMIKNVLHSA
421 RLLGDASVSF TENCVVGIQA NTERINKLMN ESLMLVTALN PHIGYDKAAK IAKTAHKNGS
481 TLKETAIELG YLTAEQFDEW VKPKDMLGPKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 253 nTPM
Expression across tissuesHPA
Tissue
- liver: 253 nTPM
- tongue: 213 nTPM
- skeletal muscle: 197 nTPM
- heart muscle: 166 nTPM
- kidney: 93 nTPM
- parathyroid gland: 88 nTPM
Single-cell type
- late primary spermatocytes: 208 nCPM
- syncytiotrophoblasts: 200 nCPM
- early spermatids: 197 nCPM
- esophageal basal cells: 128 nCPM
- cytotrophoblasts: 125 nCPM
- oocytes: 115 nCPM
Immune cell
- myeloid DC: 45 nTPM
- intermediate monocyte: 31 nTPM
- non-classical monocyte: 28 nTPM
- memory B-cell: 27 nTPM
- naive B-cell: 25 nTPM
- T-reg: 23 nTPM
Brain region
- choroid plexus: 50 nTPM
- cerebral cortex: 28 nTPM
- hypothalamus: 27 nTPM
- cerebellum: 27 nTPM
- white matter: 26 nTPM
- spinal cord: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FH.
Disease | AllUniProt
Conditions FH is implicated in, by any mechanism.
- Fumarase deficiency (FMRD) MIM:606812
Disease | GeneticClinVar
501 pathogenic / likely-pathogenic of 2,515 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary cancer-predisposing syndrome
- Hereditary leiomyomatosis and renal cell cancer
- Fumarase deficiency
- FH-related disorder
- Ovarian serous cystadenocarcinoma
Disease | ImmuneIEDB
Conditions an epitope on FH was assayed in.
- brain glioma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 1.27
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arginine metabolic process
- DNA damage response
- DNA repair
- homeostasis of number of cells within a tissue
- malate metabolic process
- positive regulation of cold-induced thermogenesis
- positive regulation of double-strand break repair via nonhomologous end joining
- regulation of arginine metabolic process
- tricarboxylic acid cycle
- urea cycle
- fumarate metabolic process
Molecular functions
- histone binding
- fumarate hydratase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Fumarate lyase family
- L-Aspartase-like
- Fumarate lyase, conserved site
- Fumarate lyase, N-terminal
- Fumarase/histidase, N-terminal
- Lyase
- Fumarate hydratase, class II
- Fumarase C, C-terminal
- Fumarase C C-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FH as an antibody target. Whether an autoantibody or antibody against FH could matter depends on whether native FH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...